Latest Robert Clarke Stories
Tom Campbell to Retire, Robert Clarke Named SCCA Pro Racing President Topeka, KS (PRWEB) July 11, 2014 SCCA Pro Racing Ltd.
Researchers at Georgetown Lombardi Comprehensive Cancer Center have uncovered a single molecule they say is a major determinant of resistance to anti-estrogen therapy used to treat or prevent breast cancer in high-risk women.
The first roadmap to mathematical modeling of a powerful basic "decision circuit" in breast cancer has been developed and published in Nature Reviews Cancer.
A study by researchers from the Georgetown Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) identifies a potential new combination therapy to "rescue" treatment sensitivity to fulvestrant in estrogen receptor positive breast cancers.
Chemical found in feverfew, long a staple of natural herbal medicine, shuts down pro-survival signal in resistant breast cancer cells.
Researchers find out why estrogen-positive tumors stop responding to commonly used drugs, pointing a way to new therapies.